Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Raymond James Maintains LumiraDx (LMDX) Outperform Recommendation
Fintel reports that on April 10, 2023, Raymond James maintained coverage of LumiraDx (NASDAQ:LMDX) with a Outperform recommendation. Analyst Price Forecast Suggests 273.74% Upside As
Raymond James Maintains LumiraDx (LMDX) Outperform Recommendation
Fintel reports that on April 7, 2023, Raymond James maintained coverage of LumiraDx (NASDAQ:LMDX) with a Outperform recommendation. Analyst Price Forecast Suggests 242.73% Upside As